| |
 |
|
Class Information
Number: 424/240.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) > Toxin or toxoid, except endotoxin (e.g., exotoxin, enterotoxin, etc.) > Bordetella (e.g., bordetella pertussis, etc.)
Description: Subject matter wherein the toxin or toxoid originates from a bacterium of the genus Bordetella.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7323183 |
Vaccine compositions including chitosan for intranasal administration and use thereof |
Jan. 29, 2008 |
| 7279169 |
Mucosal DTPa vaccines |
Oct. 9, 2007 |
| 7211263 |
Use of adenylate cyclase or bacteria producing it as vaccines against Bordetella |
May. 1, 2007 |
| RE39494 |
Inactivated mycoplasma hyopneumoniae and uses therefor |
Feb. 27, 2007 |
| 7144576 |
Modified pertussis toxin |
Dec. 5, 2006 |
| 7105161 |
Proteinaceous adjuvants |
Sep. 12, 2006 |
| 7090853 |
Noscapine derivatives as adjuvant compositions and methods of use thereof |
Aug. 15, 2006 |
| 7070781 |
Nontoxic mucosal adjuvant |
Jul. 4, 2006 |
| 7070779 |
POLYPEPTIDES CONTAINING POLYMORPHISMS OF THE REPEATED REGIONS OF PERTACTIN IN BORDETELLA PERTUSSIS, BORDETELLA PARAPERTUSSIS, AND BORDETELLA BRONCHISEPTICA, THEIR USE IN DIAGNOSTICS, AND IN IM |
Jul. 4, 2006 |
| 7056521 |
Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
Jun. 6, 2006 |
| 7045314 |
Method for the production of bacterial toxins |
May. 16, 2006 |
| 7037499 |
Adjuvant for transcutaneous immunization |
May. 2, 2006 |
| 6858211 |
Vaccines against Escherichia coli O157 infection |
Feb. 22, 2005 |
| 6814971 |
Adjuvants for use in vaccines |
Nov. 9, 2004 |
| 6713072 |
Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine |
Mar. 30, 2004 |
| 6582705 |
Acellular antibordetella vaccine |
Jun. 24, 2003 |
| 6562352 |
Vaccine compositions for mucosal delivery |
May. 13, 2003 |
| 6548287 |
Non-pyrogenic bacterial strains and use of the same |
Apr. 15, 2003 |
| 6517844 |
Compositions and method for immunizing polutry |
Feb. 11, 2003 |
| 6514499 |
Compositions exhibiting ADP-ribosyltransferase activity and methods for the preparation and use thereof |
Feb. 4, 2003 |
| 6451338 |
Liposomes containing particulate materials |
Sep. 17, 2002 |
| 6440423 |
Mutant enterotoxin effective as a non-toxic oral adjuvant |
Aug. 27, 2002 |
| 6399076 |
Acellular pertussis vaccines and methods of preparation thereof |
Jun. 4, 2002 |
| 6391318 |
Vaccine compositions including chitosan for intranasal administration and use thereof |
May. 21, 2002 |
| 6387377 |
Acellular antibordetella vaccine |
May. 14, 2002 |
| 6379676 |
Enhancing immune response in animals |
Apr. 30, 2002 |
| 6368589 |
Use of autologous promoters to express gene products in Bordetella |
Apr. 9, 2002 |
| 6322809 |
Liposomes containing particulate materials |
Nov. 27, 2001 |
| 6309648 |
Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections |
Oct. 30, 2001 |
| 6299881 |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts |
Oct. 9, 2001 |
| 6291516 |
Regulators of the hedgehog pathway, compositions and uses related thereto |
Sep. 18, 2001 |
| 6284256 |
Bordetella bronchiseptica vaccine |
Sep. 4, 2001 |
| 6245883 |
Anti-flammatory carbohydrate binding-peptides |
Jun. 12, 2001 |
| 6218166 |
Adjuvant incorporation into antigen carrying cells: compositions and methods |
Apr. 17, 2001 |
| 6214356 |
Use of adenylate cyclase or bacteria producing it as vaccines against bordetella |
Apr. 10, 2001 |
| 6210685 |
Antigenic preparations and isolation of such preparations |
Apr. 3, 2001 |
| 6149919 |
Immunogenic detoxified mutants of cholera toxin and of the toxin LT, their preparation and their use for the preparation of vaccines |
Nov. 21, 2000 |
| 6139844 |
Method for treating or eliminating a parasitic disease |
Oct. 31, 2000 |
| 6127151 |
Antigenic preparations and the isolation of such preparations |
Oct. 3, 2000 |
| 6106842 |
Extraction of cell-bound protein from bordetella |
Aug. 22, 2000 |
| 6060067 |
Process for the preparation of tetanus toxoid vaccine |
May. 9, 2000 |
| 6056960 |
Compositions exhibiting ADP-ribosyltransferase activity and methods for the preparation and use thereof |
May. 2, 2000 |
| 6051240 |
Method of separating protective components of Bordetella pertussis |
Apr. 18, 2000 |
| 6045805 |
Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent |
Apr. 4, 2000 |
| 6030625 |
Bordetella pertussis and Bordetella parapertussis strains |
Feb. 29, 2000 |
| 6027731 |
Pertussis toxin induced lymphocytosis |
Feb. 22, 2000 |
| 6019982 |
Mutant enterotoxin effective as a non-toxic oral adjuvant |
Feb. 1, 2000 |
| 6018022 |
Modification of pertussis toxin |
Jan. 25, 2000 |
| 6015560 |
Antibody recognizing endothelial cell ligand for leukocyte CR3 |
Jan. 18, 2000 |
| 6007818 |
Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent |
Dec. 28, 1999 |
|
|
|
